NCT07502157

Brief Summary

The goal of this clinical trial is to determine the feasibility of studying massage therapy in patients with gynecologic cancers while receiving infusion treatments. The central hypothesis is that it is feasible to implement a massage intervention study in an infusion center at an academic hospital, and measure pain and anxiety in patients with gynecological cancer. The main questions it aims to answer are: Can investigators evaluate feasibility to conduct a study from a design standpoint? Can investigators assess the use of randomization, blinding of assessors, potential to control the study with an attention group, and recruitment/retention processes? Can investigators successfully collect outcome measures of pain and anxiety, pre/post intervention? Researchers will investigate degree of resources needed, such as massage therapists, assessors, and timing of delivery intervention. Assess positive/negative effects on target population determining massage modality and anatomical location. Researchers will compare massage therapy to an attention control group, to see if massage therapy works to treat pain and anxiety in patients with cancer. Establish variability in outcome measures. Participants will: Be randomized and receive either massage therapy or attention control over the course of three consecutive infusion therapy treatments. Each infusion therapy treatment occurs every 2-4 weeks.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 16, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 30, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

May 11, 2026

Status Verified

March 1, 2026

Enrollment Period

4 months

First QC Date

March 16, 2026

Last Update Submit

May 6, 2026

Conditions

Keywords

Massage therapyPainAnxietyCancerFeasibility

Outcome Measures

Primary Outcomes (5)

  • Recruitment feasibility

    Number of participants enrolled within the recruitment period.

    6 months

  • Retention

    Number of participants completing the study.

    6 months

  • Randomization

    Number of participants randomized

    6 months

  • Percentage of accessors successful blinded

    Assessors will be answering yes or no to the questionnaire and percentage will be calculated.

    6 months

  • Number of participants that completed 3 or more sessions

    Adherence is defined by participant completing 3 or more sessions.

    6 months

Secondary Outcomes (3)

  • Change in Defense and Veterans Pain Rating Scale (DVPRS)

    Pre and post infusion therapy treatment (Up to 9 weeks)

  • Change in State-Trait Anxiety Inventory (STAI)

    Pre and post infusion therapy treatment (Up to 9 weeks)

  • Temporal Summation, Pain Threshold using von Frey Monofilaments

    Pre and Post infusion therapy treatment (Up to 9 weeks)

Study Arms (2)

Attention Control, No Massage Therapy

PLACEBO COMPARATOR

Attention Control, No Massage Therapy

Procedure: Attention Control

Massage Therapy

EXPERIMENTAL

Massage Therapy

Procedure: Massage Therapy

Interventions

Gynecologic patient receiving an infusion will receive massage therapy for 15-20 minutes. The patient will have a choice of a hand, foot, or posterior neck and shoulder Swedish massage.

Massage Therapy

Massage therapist sits with gynecologic patient receiving an infusion asking questions for no more than 15 minutes.

Attention Control, No Massage Therapy

Eligibility Criteria

Age18 Years - 85 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with gynecologic cancer receiving active treatment of infusion, including but not limited to chemotherapy, immunotherapy, antibiotics, and blood.
  • Patients with gynecological cancer undergoing an infusion for the first time.

You may not qualify if:

  • Patient with gynecologic cancer that has received infusion therapy anytime within the past 2 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kentucky

Lexington, Kentucky, 40506, United States

Location

MeSH Terms

Conditions

PainAnxiety DisordersNeoplasms

Interventions

Massage

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

Therapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Jill S Cole, MA, LMT, BCTMB

    University of Kentucky, Integrative Medicine and Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jill S Cole, MA, LMT, BCMTB

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 16, 2026

First Posted

March 30, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

May 11, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations